COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

COVID-19 is renowned as a multi-organ disease having subacute and long-term effects with
a broad spectrum of clinical manifestations. The evolving scientific and clinical evidence …

Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is
characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection …

Neurological symptoms have been often reported in COVID-19 disease. In the present
study, we evaluated brain damage associated with the increase of serum levels of …

The levels of several glial and neuronal plasma biomarkers have been found to increase
during the acute phase in COVID-19 patients with neurological symptoms. However …

Whether or not SARS-CoV-2 can cross from mother to fetus during a prenatal infection has
been controversial; however, recent evidence such as viral RNA detection in umbilical cord …

Coronavirus disease 2019 (COVID-19) has been linked to various neurological
complications. This meta-analysis assessed the relationship between glial fibrillary acidic …

Coronavirus disease 2019 (COVID-19) has been demonstrated to affect several systems of
the human body, including the gastrointestinal and nervous systems. The enteric nervous …

Abstract Coronavirus disease 2019 (COVID-19) has been demonstrated to affect several
systems of the human body, including the gastrointestinal and nervous systems. The enteric …